Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Proc Natl Acad Sci U S A. 1985 February; 82(3): 790–794.

PMCID: PMC397132

D Wolf and V Rotter

This article has been cited by other articles in PMC.

Abstract

The tumor antigen p53 is overproduced in transformed cells of various species, including man. HL-60 is an exceptional human tumor cell line that does not express this protein. Hybridization of polyadenylylated mRNA of these cells with a human p53 cDNA probe (p53-H14), which we cloned, had indicated a total absence of the mature-size (3.0 kilobases) or any aberrant p53 mRNA species. Analysis of the genomic HL-60 DNA indicated that the p53 gene in these cells was significantly altered. Most of the gene was deleted, and the residual p53 sequences of these cells, which show weak homology, mapped to the corresponding 5' region of the p53 gene. In agreement with previously documented results, we found that HL-60 cells have an amplified c-myc gene. We suggest that the deficiency of the p53 protein in HL-60 cells could have been overcome by using an alternative metabolic pathway. The c-myc product is a candidate for such an alternative protein.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Image
on p.791

Image
on p.792

Image
on p.793

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Lane, DP; Crawford, LV. T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979 Mar 15;278(5701):261–263. [PubMed]
Linzer, DI; Levine, AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979 May;17(1):43–52. [PubMed]
Rotter, V; Boss, MA; Baltimore, D. Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents. J Virol. 1981 Apr;38(1):336–346. [PubMed]
DeLeo, AB; Jay, G; Appella, E; Dubois, GC; Law, LW; Old, LJ. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A. 1979 May;76(5):2420–2424. [PubMed]
Rotter, V. p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells. Proc Natl Acad Sci U S A. 1983 May;80(9):2613–2617. [PubMed]
Crawford, LV; Pim, DC; Gurney, EG; Goodfellow, P; Taylor-Papadimitriou, J. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein. Proc Natl Acad Sci U S A. 1981 Jan;78(1):41–45. [PubMed]
Simmons, DT; Martin, MA; Mora, PT; Chang, C. Relationship among Tau antigens isolated from various lines of simian virus 40-transformed cells. J Virol. 1980 Jun;34(3):650–657. [PubMed]
Rotter, V; Friedman, H; Katz, A; Zerivitz, K; Wolf, D. Variation in antigenic determinants of p53 transformation-related protein obtained from various species. J Immunol. 1983 Jul;131(1):329–333. [PubMed]
Rotter, V; Abutbul, H; Wolf, D. The presence of p53 transformation-related protein in Ab-MuLV transformed cells is required for their development into lethal tumors in mice. Int J Cancer. 1983 Mar 15;31(3):315–320. [PubMed]
Wolf, D; Admon, S; Oren, M; Rotter, V. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species. Mol Cell Biol. 1984 Mar;4(3):552–558. [PubMed]
Wolf, D; Rotter, V. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol Cell Biol. 1984 Jul;4(7):1402–1410. [PubMed]
Wolf, D; Harris, N; Rotter, V. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell. 1984 Aug;38(1):119–126. [PubMed]
Dalla-Favera, R; Wong-Staal, F; Gallo, RC. Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature. 1982 Sep 2;299(5878):61–63. [PubMed]
Westin, EH; Wong-Staal, F; Gelmann, EP; Dalla-Favera, R; Papas, TS; Lautenberger, JA; Eva, A; Reddy, EP; Tronick, SR; Aaronson, SA; Gallo, RC. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2490–2494. [PubMed]
Todaro, GJ; Green, H; Swift, MR. Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science. 1966 Sep 9;153(741):1252–1254. [PubMed]
Rotter, V; Witte, ON; Coffman, R; Baltimore, D. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50. J Virol. 1980 Nov;36(2):547–555. [PubMed]
Coffman, RL; Weissman, IL. A monoclonal antibody that recognizes B cells and B cell precursors in mice. J Exp Med. 1981 Feb 1;153(2):269–279. [PubMed]
Gurney, EG; Harrison, RO; Fenno, J. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens. J Virol. 1980 Jun;34(3):752–763. [PubMed]
Harlow, E; Crawford, LV; Pim, DC; Williamson, NM. Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol. 1981 Sep;39(3):861–869. [PubMed]
Kessler, SW. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 1975 Dec;115(6):1617–1624. [PubMed]
Laemmli, UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
Okayama, H; Berg, P. High-efficiency cloning of full-length cDNA. Mol Cell Biol. 1982 Feb;2(2):161–170. [PubMed]
Gubler, U; Hoffman, BJ. A simple and very efficient method for generating cDNA libraries. Gene. 1983 Nov;25(2-3):263–269. [PubMed]
Hoyt, MA; Knight, DM; Das, A; Miller, HI; Echols, H. Control of phage lambda development by stability and synthesis of cII protein: role of the viral cIII and host hflA, himA and himD genes. Cell. 1982 Dec;31(3 Pt 2):565–573. [PubMed]
Southern, EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
Rigby, PW; Dieckmann, M; Rhodes, C; Berg, P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. [PubMed]
Auffray, C; Rougeon, F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980 Jun;107(2):303–314. [PubMed]
Aviv, H; Leder, P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1408–1412. [PubMed]
Thomas, PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5201–5205. [PubMed]
Oren, M; Levine, AJ. Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen. Proc Natl Acad Sci U S A. 1983 Jan;80(1):56–59. [PubMed]
Dalla-Favera, R; Gelmann, EP; Martinotti, S; Franchini, G; Papas, TS; Gallo, RC; Wong-Staal, F. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A. 1982 Nov;79(21):6497–6501. [PubMed]
Land, H; Parada, LF; Weinberg, RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304(5927):596–602. [PubMed]
Ruley, HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 1983 Aug 18;304(5927):602–606. [PubMed]
Milner, J; Milner, S. SV40-53K antigen: a possible role for 53K in normal cells. Virology. 1981 Jul 30;112(2):785–788. [PubMed]
Mercer, WE; Nelson, D; DeLeo, AB; Old, LJ; Baserga, R. Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6309–6312. [PubMed]
Reich, NC; Levine, AJ. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature. 308(5955):199–201. [PubMed]
Weiss, R. The myc oncogene in man and birds. Nature. 1982 Sep 2;299(5878):9–10. [PubMed]
Donner, P; Greiser-Wilke, I; Moelling, K. Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature. 1982 Mar 18;296(5854):262–269. [PubMed]
Rotter, V; Abutbul, H; Ben-Ze'ev, A. P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts. EMBO J. 1983;2(7):1041–1047. [PubMed]
Kelly, K; Cochran, BH; Stiles, CD; Leder, P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 1983 Dec;35(3 Pt 2):603–610. [PubMed]
Campisi, J; Gray, HE; Pardee, AB; Dean, M; Sonenshein, GE. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell. 1984 Feb;36(2):241–247. [PubMed]
Bienz, B; Zakut-Houri, R; Givol, D; Oren, M. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J. 1984 Sep;3(9):2179–2183. [PubMed]
Eliyahu, D; Raz, A; Gruss, P; Givol, D; Oren, M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 1984 Dec 13;312(5995):646–649. [PubMed]
Parada, LF; Land, H; Weinberg, RA; Wolf, D; Rotter, V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984 Dec 13;312(5995):649–651. [PubMed]